Unique ID issued by UMIN | UMIN000010144 |
---|---|
Receipt number | R000011829 |
Scientific Title | Study of the clinical efficacy and number of days of tebipenem pivoxil administration for the treatment of pediatric bacterial pneumonia. |
Date of disclosure of the study information | 2013/03/01 |
Last modified on | 2017/05/22 17:33:36 |
Study of the clinical efficacy and number of days of tebipenem pivoxil administration for the treatment of pediatric bacterial pneumonia.
Clinical efficacy of tebiepenem pivoxil for the treatment of childhood pneumonia.
Study of the clinical efficacy and number of days of tebipenem pivoxil administration for the treatment of pediatric bacterial pneumonia.
Clinical efficacy of tebiepenem pivoxil for the treatment of childhood pneumonia.
Japan |
Pediatric bacterial pneumonia
Pediatrics |
Others
NO
Assessment of the clinical efficacy of TBPM-PI at a dose of 6 mg/kg twice daily in principle for 3 days (up to 7 days) in patients who are candidates for in-hospital treatment as well as candidates for outpatient treatment but who are suspected of being infected with resistant bacteria.
Safety,Efficacy
Confirmatory
Not applicable
* Clinical effect 1 week after the end of treatment (i.e., determination of healing).
* Adverse events occurring during the assessment period (with undeniable causality: side effects).
* Bacteriological efficacy at the end of treatment (day 3 to day 8).
* Clinical efficacy 2 to 3 days after the initiation of treatment (day 3 to day 4) and at the end of treatment (day 3 to day 8).
* Changes in body temperature and laboratory values.
Observational
0 | years-old | <= |
16 | years-old | > |
Male and Female
1)Outpatients and hospitalized patients are eligible.
2) All of the following conditions must be met:
(1) Seven days or less after disease onset.
(2) Presence of symptoms of respiratory infection, such as fever (over 37.5 degrees centigrade), cough, and expectorated sputum.
(3) Images of new infiltration visible on the chest radiograph.
(4) WBC count over 15,000/uL or CRP level over 4 mg/dL.
3) Pediatric patients with a moderate or mild form of the disease or with a risk of being infected by resistant bacteria according to the standard criteria described in the 2011 guidelines.
1) Pediatric patients with other infectious foci who are potentially unresponsive to treatment with orally administered medication.
2) Pediatric patients in whom the efficacy and safety of the study drug is difficult to determine because of a progressive, complicated, or severe underlying disease believed to critically influence the onset of the infection, its clinical course, and therapeutic efficacy.
3) Pediatric patients with convulsive disorders, such as epilepsy, as an underlying disease.
4) Pediatric patients with a lipid metabolism disorder or congenital carnitine deficiency.
5) Pediatric patients with severe hepatic or renal dysfunction.
To determine whether the pediatric patient is appropriate for this study, the attending physician must judge the child's condition on the basis of the following laboratory values:
- Liver function values: AST (GOT) levels over 100 IU/L or ALT (GPT) levels over 100 IU/L.
- Renal function values: BUN over 25 mg/dL or serum creatinine levels over 2.0 mg/dL.
6) Pediatric patients with poor oral ingestion or receiving parenteral feeding.
7) Pediatric patients with a history of allergy to beta-lactam antibiotics (e.g.,carbapenems, penicillin, and cephem).
8) Pediatric patients who have received other antibiotics and exhibited improvements.
9) Pediatric patients deemed inappropriate for this study by the attending physician.
100
1st name | |
Middle name | |
Last name | Kazunobu Ouchi |
Kawasaki Medical School
Department of Pediatrics
577, Matsushima, Kurashiki-shi, Okayama
086-462-1111
1st name | |
Middle name | |
Last name | Hiroto Akaike |
Kawasaki Medical School
Department of Pediatrics
577, Matsushima, Kurashiki-shi, Okayama
086-462-1111
Department of Pediatrics, Kawasaki Medical School
None
Self funding
Japan
Keio University School of Medicine
Niigata University Medical and Dental Hospital
Osaka Rosai Hospital
Sotobo Children's Clinic, Medical Corporation Shigyo-no-kai
Kurosaki Children's Clinic
etc
NO
川崎医科大学(岡山県)
新潟大学(新潟県)
大阪労災病院(大阪府)
外房こどもクリニック(千葉県)
くろさきこどもクリニック(千葉県)
国立病院機構東京医療センター(東京都)
旭川厚生病院(北海道)
富士重工業健康保険組合 太田記念病院(群馬県)
博慈会記念総合病院(東京都)
久留米大学医学部(福岡県)
長井小児科医院(福岡県)
いけざわこどもクリニック(福岡県)
横浜南共済病院(神奈川県)
横須賀共済病院(神奈川県)
県立広島病院(広島県)
2013 | Year | 03 | Month | 01 | Day |
Unpublished
Completed
2012 | Year | 12 | Month | 01 | Day |
2013 | Year | 02 | Month | 25 | Day |
2014 | Year | 02 | Month | 28 | Day |
2015 | Year | 02 | Month | 28 | Day |
2015 | Year | 04 | Month | 30 | Day |
2015 | Year | 06 | Month | 30 | Day |
National Hospital Organization Tokyo Medical Center
Asahikawa Kosei Hospital
Fuji Heavy Industries Ltd., Health Insurance Society General Ota Hospital
Hakujikai Memorial Hospital
Kurume University School of Medicine
Yokohama Minami Kyosai Hospital
Yokosuka Kyosai Hospital
Prefectural University of Hiroshima
2013 | Year | 03 | Month | 01 | Day |
2017 | Year | 05 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011829
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |